{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T09:28:21Z","timestamp":1785403701942,"version":"3.56.0"},"reference-count":55,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"crossref"}]},{"id":[{"id":"https:\/\/ror.org\/00789fa95","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Leucine-rich-repeat kinase 2 (LRRK2) is a multidomain protein highly expressed in immune cells and implicated in the regulation of immune functions including immune signaling, cytokine release and autophagy. LRRK2 is one of the therapeutic targets in Parkinson\u2019s Disease (PD). Aberrant activation of LRRK2 can also contribute to intestinal inflammation, mainly in inflammatory bowel disease (IBD). Hence the modulation of LRRK2 may influence gut inflammation providing an improvement in disease outcomes. Over the years, microRNAs (miRNAs) have acquired much attention thanks to their potential as therapeutic targets in several pathological conditions, including inflammatory disorders. In this study, we aimed to examine the ability of miR-369-3p in the modulation of autophagy targeting LRRK2 expression. Bioinformatics analysis revealed that Lrrk2 is a target gene of miR-369-3p, and LRRK2 expression was increased in ulcerative colitis patients compared with that in a healthy control. In in vitro analysis, we validated that mimic transfection with miR-369-3p in Raw264.7 significantly reduced the expression of LRRK2 both in basal and inflammatory conditions. Moreover, the inhibition of LRRK2 limited the nuclear translocation of Nuclear factor kappa B (NF-\u03baB) induced by lipopolysaccharide (LPS) stimulation. In turn, we found that, in inflammatory conditions, the intracellular increase in miR-369-3p precluded the inhibition of autophagy by LRRK2 by restoring autophagy marker light chain 3 (LC3)II\/I ratio, BECLIN-1 and decreasing p62 expression. Furthermore, we detected that the upregulation of miR-369-3p decreased the release of pro-inflammatory mediators Tumor necrosis factor (TNF), C-C motif ligand 2\/Monocyte chemoattractant protein-1 (CCL2\/MCP-1), C-C motif ligand 3\/Macrophage inflammatory protein-1 alpha (CCL3\/MIP-1\u03b1) and C-C motif ligand 5\/Regulated on activation, normal T-cell expressed and secreted (CCL5\/RANTES) and increased the anti-inflammatory cytokine interleukin 10 (IL-10) in response to LPS. This study supports the anti-inflammatory potential of miR-369-3p in immune cells and suggests the potential of miR-369-3p as a therapeutic agent in the treatment of acute intestinal inflammatory conditions such as ulcerative colitis.<\/jats:p>","DOI":"10.3390\/ijms27073220","type":"journal-article","created":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T09:26:12Z","timestamp":1775121972000},"page":"3220","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["miR-369-3p Modulates LRRK2-Mediated Inflammation and Autophagy in RAW264.7 Macrophages"],"prefix":"10.3390","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0273-2825","authenticated-orcid":false,"given":"Viviana","family":"Scalavino","sequence":"first","affiliation":[{"name":"National Institute of Gastroenterology S. De Bellis, IRCCS Research Hospital, Via Turi 27, 70013 Castellana Grotte, Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7988-1917","authenticated-orcid":false,"given":"Emanuele","family":"Piccinno","sequence":"additional","affiliation":[{"name":"National Institute of Gastroenterology S. De Bellis, IRCCS Research Hospital, Via Turi 27, 70013 Castellana Grotte, Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-7940-4977","authenticated-orcid":false,"given":"Ilaria","family":"Grassi","sequence":"additional","affiliation":[{"name":"National Institute of Gastroenterology S. De Bellis, IRCCS Research Hospital, Via Turi 27, 70013 Castellana Grotte, Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1661-5504","authenticated-orcid":false,"given":"Raffaele","family":"Armentano","sequence":"additional","affiliation":[{"name":"National Institute of Gastroenterology S. De Bellis, IRCCS Research Hospital, Via Turi 27, 70013 Castellana Grotte, Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5140-8060","authenticated-orcid":false,"given":"Gianluigi","family":"Giannelli","sequence":"additional","affiliation":[{"name":"National Institute of Gastroenterology S. De Bellis, IRCCS Research Hospital, Via Turi 27, 70013 Castellana Grotte, Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2971-0802","authenticated-orcid":false,"given":"Grazia","family":"Serino","sequence":"additional","affiliation":[{"name":"National Institute of Gastroenterology S. De Bellis, IRCCS Research Hospital, Via Turi 27, 70013 Castellana Grotte, Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,4,2]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1042\/BST20180463","article-title":"LRRK2 regulation of immune-pathways and inflammatory disease","volume":"47","author":"Wallings","year":"2019","journal-title":"Biochem. Soc. Trans."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Marchand, A., Drouyer, M., Sarchione, A., Chartier-Harlin, M.-C., and Taymans, J.-M. (2020). LRRK2 phosphorylation, more than an epiphenomenon. Front. Neurosci., 14.","DOI":"10.3389\/fnins.2020.00527"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Zhang, X., and Kortholt, A. (2023). LRRK2 structure-based activation mechanism and pathogenesis. Biomolecules, 13.","DOI":"10.3390\/biom13040612"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"105837","DOI":"10.1016\/j.nbd.2022.105837","article-title":"The multifaceted role of LRRK2 in Parkinson\u2019s disease: From human iPSC to organoids","volume":"173","author":"Oun","year":"2022","journal-title":"Neurobiol. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"6871","DOI":"10.1111\/febs.16099","article-title":"LRRK2 recruitment, activity, and function in organelles","volume":"289","author":"Cookson","year":"2022","journal-title":"FEBS J."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"eadi7907","DOI":"10.1126\/sciimmunol.adi7907","article-title":"Macrophage LRRK2 hyperactivity impairs autophagy and induces Paneth cell dysfunction","volume":"9","author":"Sun","year":"2024","journal-title":"Sci. Immunol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1002\/acn3.51776","article-title":"LRRK2 and Parkinson\u2019s disease: From genetics to targeted therapy","volume":"10","author":"Sosero","year":"2023","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"105724","DOI":"10.1016\/j.nbd.2022.105724","article-title":"LRRK2 as a target for modulating immune system responses","volume":"169","author":"Russo","year":"2022","journal-title":"Neurobiol. Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13024-019-0344-2","article-title":"LRRK2 Biology from structure to dysfunction: Research progresses, but the themes remain the same","volume":"14","author":"Berwick","year":"2019","journal-title":"Mol. Neurodegener."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.ygeno.2021.11.037","article-title":"LRRK2 correlates with macrophage infiltration in pan-cancer","volume":"114","author":"Yan","year":"2022","journal-title":"Genomics"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Wang, Y., Gao, J.Z., Sakaguchi, T., Maretzky, T., Gurung, P., Narayanan, N.S., Short, S., Xiong, Y., and Kang, Z. (2024). LRRK2 G2019S promotes colon cancer potentially via LRRK2\u2013GSDMD axis-mediated gut inflammation. Cells, 13.","DOI":"10.3390\/cells13070565"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1056\/NEJMra2002697","article-title":"Pathophysiology of inflammatory bowel diseases","volume":"383","author":"Chang","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e714","DOI":"10.1002\/mco2.714","article-title":"The interaction of innate immune and adaptive immune system","volume":"5","author":"Wang","year":"2024","journal-title":"MedComm"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1073984","DOI":"10.1155\/2023\/1073984","article-title":"Intestinal immune imbalance is an alarm in the development of IBD","volume":"2023","author":"Hu","year":"2023","journal-title":"Mediat. Inflamm."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Monteleone, G., Calisi, C., Salvatori, S., and Marafini, I. (2025). Fundamental and emerging insights into innate and adaptive immunity in inflammatory bowel diseases. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1665530"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1038\/ni.2113","article-title":"The kinase LRRK2 is a regulator of the transcription factor NFAT that modulates the severity of inflammatory bowel disease","volume":"12","author":"Liu","year":"2011","journal-title":"Nat. Immunol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"110527","DOI":"10.1016\/j.ygeno.2022.110527","article-title":"LRRK2 deficiency mitigates colitis progression by favoring resolution of inflammation and restoring homeostasis of gut microbiota","volume":"114","author":"Yan","year":"2022","journal-title":"Genomics"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"eaan8162","DOI":"10.1126\/scitranslmed.aan8162","article-title":"An increase in LRRK2 suppresses autophagy and enhances Dectin-1\u2013induced immunity in a mouse model of colitis","volume":"10","author":"Takagawa","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/s41576-023-00611-y","article-title":"microRNAs in action: Biogenesis, function and regulation","volume":"24","author":"Shang","year":"2023","journal-title":"Nat. Rev. Genet."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.ncrna.2023.07.002","article-title":"MiRNAs and lncRNAs in the regulation of innate immune signaling","volume":"8","author":"Gareev","year":"2023","journal-title":"Non-Coding RNA Res."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Scalavino, V., Liso, M., and Serino, G. (2020). Role of microRNAs in the regulation of dendritic cell generation and function. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21041319"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.1111\/febs.14482","article-title":"A guide to miRNAs in inflammation and innate immune responses","volume":"285","author":"Nejad","year":"2018","journal-title":"FEBS J."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Chandan, K., Gupta, M., and Sarwat, M. (2020). Role of host and pathogen-derived microRNAs in immune regulation during infectious and inflammatory diseases. Front. Immunol., 10.","DOI":"10.3389\/fimmu.2019.03081"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.7150\/ijbs.59904","article-title":"Roles of microRNAs in inflammatory bowel disease","volume":"17","author":"Jung","year":"2021","journal-title":"Int. J. Biol. Sci."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Miao, Z.-X., Meng, H., Wang, J., Hou, X.-T., Cheng, W.-W., Liu, B.-H., Zhang, Q.-G., and Yuan, S. (2025). Autophagy in inflammatory bowel disease: Immunization, etiology, and therapeutic potential. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1543040"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"mjac015","DOI":"10.1093\/jmcb\/mjac015","article-title":"The molecular regulation of autophagy in antimicrobial immunity","volume":"14","author":"Qin","year":"2022","journal-title":"J. Mol. Cell Biol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1093\/ibd\/izaf279","article-title":"The role of autophagy in inflammatory diseases: Challenges and therapeutic potential","volume":"32","author":"Palomares","year":"2026","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Sokal-Dembowska, A., Jarmakiewicz-Czaja, S., Helma, K., and Filip, R. (2025). The Role of microRNAs in Inflammatory Bowel Disease. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26104750"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"7565076","DOI":"10.1155\/2018\/7565076","article-title":"The role of autophagy and related microRNAs in inflammatory bowel disease","volume":"2018","author":"Wang","year":"2018","journal-title":"Gastroenterol. Res. Pract."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Dweep, H., Gretz, N., and Sticht, C. (2014). miRWalk database for miRNA\u2013target interactions. RNA Mapping: Methods and Protocols, Springer.","DOI":"10.1007\/978-1-4939-1062-5_25"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"105806","DOI":"10.1016\/j.nbd.2022.105806","article-title":"The role of LRRK2 in the periphery: Link with Parkinson\u2019s disease and inflammatory diseases","volume":"172","author":"Tsafaras","year":"2022","journal-title":"Neurobiol. Dis."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1097\/MIB.0000000000000535","article-title":"Strong upregulation of AIM2 and IFI16 inflammasomes in the mucosa of patients with active inflammatory bowel disease","volume":"21","author":"Vanhove","year":"2015","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/MPG.0000000000001898","article-title":"Molecular comparison of adult and pediatric ulcerative colitis indicates broad similarity of molecular pathways in disease tissue","volume":"67","author":"Li","year":"2018","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"eadh1641","DOI":"10.1126\/scisignal.adh1641","article-title":"The NF-\u03baB signaling system in the immunopathogenesis of inflammatory bowel disease","volume":"17","author":"Mukherjee","year":"2024","journal-title":"Sci. Signal."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Zheng, Y., Yu, Y., Chen, X.-F., Yang, S.-L., Tang, X.-L., and Xiang, Z.-G. (2021). Intestinal macrophage autophagy and its pharmacological application in inflammatory bowel disease. Front. Pharmacol., 12.","DOI":"10.3389\/fphar.2021.803686"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/s41531-022-00297-9","article-title":"Effect of LRRK2 protein and activity on stimulated cytokines in human monocytes and macrophages","volume":"8","author":"Hughes","year":"2022","journal-title":"npj Park. Dis."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"105721","DOI":"10.1016\/j.nbd.2022.105721","article-title":"Convergence of signalling pathways in innate immune responses and genetic forms of Parkinson\u2019s disease","volume":"169","author":"Mamais","year":"2022","journal-title":"Neurobiol. Dis."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/ng.3359","article-title":"Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations","volume":"47","author":"Liu","year":"2015","journal-title":"Nat. Genet."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"eaai7795","DOI":"10.1126\/scitranslmed.aai7795","article-title":"Functional variants in the LRRK2 gene confer shared effects on risk for Crohn\u2019s disease and Parkinson\u2019s disease","volume":"10","author":"Hui","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00401-023-02595-9","article-title":"Mutant LRRK2 exacerbates immune response and neurodegeneration in a chronic model of experimental colitis","volume":"146","author":"Cabezudo","year":"2023","journal-title":"Acta Neuropathol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1093\/hmg\/dds470","article-title":"MicroRNA-205 regulates the expression of Parkinson\u2019s disease-related leucine-rich repeat kinase 2 protein","volume":"22","author":"Cho","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"ref_42","first-page":"724","article-title":"MicroRNA-599 regulates the development of Parkinson\u2019s disease through mediating LRRK2 expression","volume":"23","author":"Wu","year":"2019","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_43","first-page":"977","article-title":"Using extracellular miRNA signatures to identify patients with LRRK2-related Parkinson\u2019s disease","volume":"14","author":"Braunger","year":"2024","journal-title":"J. Park. Dis."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12929-019-0512-2","article-title":"Autophagy: Roles in intestinal mucosal homeostasis and inflammation","volume":"26","author":"Haq","year":"2019","journal-title":"J. Biomed. Sci."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Shao, B.-Z., Yao, Y., Zhai, J.-S., Zhu, J.-H., Li, J.-P., and Wu, K. (2021). The role of autophagy in inflammatory bowel disease. Front. Physiol., 12.","DOI":"10.3389\/fphys.2021.621132"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"15942","DOI":"10.1038\/s41598-020-72991-8","article-title":"miR-369-3p modulates inducible nitric oxide synthase and is involved in regulation of chronic inflammatory response","volume":"10","author":"Scalavino","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1801390","DOI":"10.1002\/mnfr.201801390","article-title":"Quercetin-Induced miR-369-3p Suppresses Chronic Inflammatory Response Targeting C\/EBP-\u03b2","volume":"63","author":"Galleggiante","year":"2019","journal-title":"Mol. Nutr. Food Res."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Scalavino, V., Piccinno, E., Valentini, A.M., Mastronardi, M., Armentano, R., Giannelli, G., and Serino, G. (2022). A novel mechanism of immunoproteasome regulation via miR-369-3p in intestinal inflammatory response. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232213771"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Scalavino, V., Piccinno, E., Valentini, A.M., Schena, N., Armentano, R., Giannelli, G., and Serino, G. (2023). miR-369-3p modulates intestinal inflammatory response via BRCC3\/NLRP3 inflammasome axis. Cells, 12.","DOI":"10.3390\/cells12172184"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Scalavino, V., Piccinno, E., Labarile, N., Armentano, R., Giannelli, G., and Serino, G. (2024). Anti-Inflammatory Effects of miR-369-3p via PDE4B in Intestinal Inflammatory Response. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25158463"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Scalavino, V., Piccinno, E., Giannelli, G., and Serino, G. (2025). miR-369-3p Ameliorates Inflammation and Apoptosis in Intestinal Epithelial Cells via the MEK\/ERK Signaling Pathway. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26094288"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/s41423-025-01310-w","article-title":"NF-\u03baB in inflammation and cancer","volume":"22","author":"Mao","year":"2025","journal-title":"Cell. Mol. Immunol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1111\/jgh.15550","article-title":"SETD8 involved in the progression of inflammatory bowel disease via epigenetically regulating p62 expression","volume":"36","author":"Chen","year":"2021","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1186\/s12967-025-06354-0","article-title":"Recent advances in targeting LRRK2 for Parkinson\u2019s disease treatment","volume":"23","author":"Karami","year":"2025","journal-title":"J. Transl. Med."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"115475","DOI":"10.1016\/j.ejmech.2023.115475","article-title":"Small-molecule LRRK2 inhibitors for PD therapy: Current achievements and future perspectives","volume":"256","author":"Hu","year":"2023","journal-title":"Eur. J. Med. Chem."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/7\/3220\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T04:19:07Z","timestamp":1775276347000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/7\/3220"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,2]]},"references-count":55,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["ijms27073220"],"URL":"https:\/\/doi.org\/10.3390\/ijms27073220","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,2]]}}}